Group 1 - Yihau New Materials plans to reduce its shareholding by up to 1% of the company's total shares, amounting to 165,500 shares, due to personal funding needs [1] - Fuxing Pharmaceutical's subsidiary has received approval for a new indication for its drug, which is used in the treatment of certain types of breast cancer [1][2] - Shantui Co. has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [3] Group 2 - Sierte's chairman plans to increase his shareholding by an amount between 3 million to 6 million yuan [4] - Borui Pharmaceutical's BGM0504 tablet has received approval for clinical trials in overweight and obese adults [5] - Ganyue Expressway reported vehicle toll service revenue of 349 million yuan for August [6] Group 3 - Chip Microelectronics has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [7] - Lingrui Pharmaceutical's director plans to reduce his shareholding by up to 200,000 shares, representing 0.0353% of the total shares [8] - Jiahu Energy has adjusted its share repurchase price limit to 11.63 yuan per share [10] Group 4 - Spring Airlines reported a year-on-year increase of 12.23% in passenger turnover for August [11] - Kaida has received an invention patent for a self-calibrating sensor technology [12] - Chuanheng Co. has obtained a new utility model patent aimed at improving industrial waste utilization [14] Group 5 - Huashi Technology received a government subsidy of 2.21 million yuan, accounting for 22.71% of its latest audited net profit [15] - Shanghai Pharmaceuticals' controlling shareholder plans to increase its H-share holdings by up to 74 million shares [16] - Hongrun Construction has won a bid for a significant segment of the Shanghai Metro Line 21 project, valued at 126 million yuan [18] Group 6 - Sanfangxiang plans to invest 100 million yuan to establish a wholly-owned subsidiary focused on green technology [19] - Lao Fengxiang's subsidiaries plan to jointly invest in luxury goods sales and gold refining companies [20][21] - China Eastern Airlines reported an 8.72% year-on-year increase in passenger turnover for August [22] Group 7 - Inner Mongolia First Machinery has signed a railway freight car procurement contract worth 186 million yuan [22] - Jiuqiang Bio has received five invention patents related to diagnostic reagents [24] - Longmag Technology plans to invest 210 million yuan in its second phase project in Vietnam [25] Group 8 - Galaxy Magnetics plans to acquire 100% equity of Kyoto Longtai, with its stock suspended for trading [26] - Jinlong Co.'s controlling shareholder will have 30 million shares auctioned [27] - Haishi Co.'s controlling shareholder has released the pledge on 29.97 million shares [28] Group 9 - Qiu Tianwei plans to reduce its shareholding by up to 1.17% of the total shares [29] - Xiaocheng Technology's directors plan to reduce their shareholding by a total of 0.08% [30] - Victory Co. reported that Sunshine Life Insurance has reduced its shareholding by 4.4 million shares [31] Group 10 - Xindong Technology plans to distribute a cash dividend of 0.156 yuan per share [32] - Huaqin Technology plans to distribute a cash dividend of 0.13 yuan per share [33] - Kexing Pharmaceutical's controlling shareholder intends to transfer 5% of the company's shares [35] Group 11 - Guojin Securities has completed the repayment of its second short-term financing bond for 1.0205 billion yuan [38] - Chunhui Intelligent Control's application for asset acquisition has been accepted by the Shenzhen Stock Exchange [39] - Chaohongji has submitted its H-share issuance application to the Hong Kong Stock Exchange [40] Group 12 - Tianyue Advanced has fully exercised its over-allotment option, involving 716,180 H-shares [40] - Chengfeng Technology's vice president has resigned due to internal adjustments [41] - Yingpais plans to establish a 100 million yuan technology sports industry investment fund [43]

深圳秋田微电子股份有限公司 关于新增募集资金专户开立完成及 签订募集资金监管协议的公告 证券代码：300939 证券简称：秋田微 公告编号：2025-045 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 深圳秋田微电子股份有限公司（以下简称"公司"）于 2025 年 08 月 20 日召 开第三届董事会第七次会议、第三届监事会第七次会议，审议通过了《关于新增 募集资金专户并授权签订募集资金监管协议的议案》，同意公司在兴业银行股份 有限公司深圳龙岗支行新增设立募集资金专项账户，用于募投项目"深圳产业基 地"的资金存储、使用和管理，并授权董事长或其指定的授权代理人办理上述募 集资金专项账户的开立、募集资金监管协议签署等相关事项。具体内容详见公司 于 2025 年 08 月 21 日披露在中国证监会指定信息披露网站巨潮资讯网 （www.cninfo.com.cn）的《关于新增募集资金专户并授权签订募集资金监管协议 的公告》。 近日，公司在兴业银行股份有限公司深圳龙岗支行开立了募集资金专项账 户，并与国信证券股份有限公司、兴业银行股份有限公司深圳龙岗支行签订了《募 ...

格隆汇9月14日丨秋田微(300939.SZ)公布，公司特定股东赣州春华赋投资合伙企业(有限合伙)、赣州秋 实赋投资合伙企业(有限合伙)、赣州谷雨赋投资合伙企业(有限合伙)计划于2025年10月14日至2026年1月 13日以集中竞价交易或大宗交易方式减持公司股份，合计减持数量不超过1,265,300股，占剔除公司回购 专用账户股份后总股本比例1.07%。 ...

Core Points - Akita Micro announced that several investment partnerships and individuals plan to reduce their holdings in the company between October 14, 2025, and January 13, 2026, through centralized bidding or block trading [1] - The total number of shares to be reduced is up to 1.2653 million shares, which accounts for 1.07% of the total share capital after excluding shares in the company's repurchase special account [1] - The reason for the reduction is stated as personal funding needs [1]

每经头条（nbdtoutiao）——重大突破！中国这款新药，中美官方都认定有突破性疗效！世界肺癌大会 沸腾了 （记者 王晓波） 每经AI快讯，秋田微（SZ 300939，收盘价：35.89元）9月14日晚间发布公告称，分别持有深圳秋田微 电子股份有限公司约109万股（占剔除公司回购专用账户股份后总股本比例为0.92%）、约108万股（占 剔除公司回购专用账户股份后总股本比例为0.91%）及约79万股（占剔除公司回购专用账户股份后总股 本比例为0.66%）的股东赣州春华赋投资合伙企业（有限合伙）、赣州秋实赋投资合伙企业（有限合 伙）与赣州谷雨赋投资合伙企业（有限合伙），计划于本减持计划公告之日起15个交易日之后的三个月 内（即2025年10月14日至2026年1月13日，窗口期不减持）以集中竞价交易或大宗交易方式减持公司股 份分别不超过约48万股（占剔除公司回购专用账户股份后总股本比例为0.4%）、约45万股（占剔除公 司回购专用账户股份后总股本比例为0.38%）、约34万股（占剔除公司回购专用账户股份后总股本比例 为0.29%），合计约127万股（占剔除公司回购专用账户股份后总股本比例为1.07%）。 公司职 ...

证券代码：300939 证券简称：秋田微 公告编号：2025-044 深圳秋田微电子股份有限公司 关于特定股东及职工代表董事、高级管理人员 减持股份预披露公告 公司特定股东赣州春华赋投资合伙企业（有限合伙），赣州秋实赋投资合伙 企业（有限合伙），赣州谷雨赋投资合伙企业（有限合伙）与公司职工代表董事、 副总经理张凤，财务负责人石俊，副总经理洪俊斌，副总经理王细昂保证向本公 司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 序号 股东名称 股东性质 持股总数（股） 占总股本比例（%） 1 春华赋 董事、高管/员工持股平台 1,090,910 0.92 2 秋实赋 董事、高管/员工持股平台 1,080,270 0.91 3 谷雨赋 董事、高管/员工持股平台 787,220 0.66 合计 2,958,400 2.49 （二）间接持股职工代表董事、高级管理人员基本情况 | | | 1、分别持有深圳秋田微电子股份有限公司（以下简称"公司"或"秋田微"） 1,090,910 股（占剔除公司回购专用账户股份后总股本比例 0 ...

秋田微公告，股东春华赋拟于2025年10月14日至2026年01月13日通过集中竞价或大宗交易减持不超 47.76万股，占0.40%；秋实赋拟减持不超44.89万股，占0.38%；谷雨赋拟减持不超33.88万股，占 0.29%；石俊拟减持24075股，占0.02%；洪俊斌拟减持43734股，占0.04%；张凤拟减持37161股，占 0.03%；王细昂拟减持17636股，占0.01%；合计减持股份不超126.53万股，占1.07%。 ...

（原标题：秋田微(300939.SZ)产品可应用于智能机器人） 格隆汇9月10日丨秋田微(300939.SZ)在互动平台表示，公司主要从事液晶显示及触控产品的研发、设计、生产和销售，公司产品可应用于智能机 器人。 ...

证券日报网讯9月5日晚间，秋田微（300939）发布公告称，选举张凤女士为公司第三届董事会职工代表 董事。 ...

秋田微公告，公司非独立董事、副总经理兼董事会秘书王亚彬因内部治理结构调整，辞去非独立董事职 务，但仍将继续担任副总经理和董事会秘书。同时，公司职工代表大会选举张凤为第三届董事会职工代 表董事，任期至第三届董事会届满之日。 ...